| (I1266) |
Introduction. |
|
M. Wehling (Mannheim) |
| (I1267) |
Diuretics in heart failure — pathophysiological bases and therapeutic consequenses. |
|
R. Düsing (Bonn) |
| (I1268) |
Impact of diuretic therapy on clinical outcomes and prognosis in heart failure — what makes the difference? |
|
C. Brater (Indianapolis IN, US) |
| (I1269) |
Diuretics in heart failure — pharmacoeconomic consequences of different outcomes. |
|
J.G.F. Cleland (Cottingham, GB) |
| (I1270) |
Torasemide and myocardial remodelling in patients with heart failure. |
|
J. Diez (Pamplona, ES) |